XL228 is primarily utilized in the field of medical research, particularly in the study and treatment of cancer. It functions as a multi-targeted kinase inhibitor, which means it can interfere with various enzymes that are involved in the growth and proliferation of cancer cells. Researchers use XL228 to explore its potential in inhibiting pathways that are crucial for tumor survival and progression. This makes it a valuable compound in the development of targeted therapies, aiming to improve the efficacy of cancer treatments while minimizing the impact on healthy cells. Its application is significant in preclinical studies, where it helps in understanding the molecular mechanisms of cancer and in the design of more effective therapeutic strategies.